Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout Europe, Canada and Australasia brings together pioneering research with cutting-edge cultivation, extraction, and production. Amidst a rapid growth trajectory, the emphasis on quality and expertise aims to ensure the delivery of safe and legal cannabis.
Curaleaf International's network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal; an EU-GMP processing, quality assurance and research site in Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.
Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.
Company Details
- Employees
- 114
- Founded
- -
- Address
- Wogan House, 99 Great Portland Street, London,england W1w 7ny,united Kingdom
- Industry
- Alternative Medicine
- NAICS
-
Offices of All Other Miscellaneous Health Practitioners
- Website
- emmac.com
- Keywords
- informs the campaigns we share..
- HQ
- London, England
Curaleaf International Questions
Curaleaf International's website is emmac.com
Curaleaf International's LinkedIn profile is https://uk.linkedin.com/company/curaleafint
Curaleaf International has
114 employees.
View email and phone details for 114
employees at Curaleaf International.
Curaleaf International's industry is
Alternative Medicine
Curaleaf International's top competitors are
Cannprisma Enhanced Medical Cannabis,
Cannabis Europa,
Curaleaf Pharmacy,
Somaí,
Curaleaf Clinic,
Tilray Brands, Inc.,
Curaleaf Laboratories,
Clever Leaves,
Montu Uk,
Curaleaf.
Curaleaf International's categories are Alternative Medicine
Curaleaf International's founding year is 2018
